CCL13 and major depressive disorder: A significantly (p = 0.002) higher serum MCP-4 levels were also observed in MDD patients (70.49±6.45 pg/ml) compared to HCs (40.21±4.09 pg/ml) indicating that this chemokine might be associated with the disease pathogenesis (Table 2 and Fig 1).